Acadia Pharma (ACAD.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec12

Akorda Pharma Receives FDA Approval for DAYBUE STIX

13:28

Nov6

Acadia Pharma released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 278.63 M (forecast USD 276.54 M), actual EPS USD 0.42 (forecast USD 0.1435)

00:00

Acadia Pharma released FY2025 9 Months earnings on November 5 After-Market (EST), actual revenue USD 787.52 M, actual EPS USD 0.6888

00:00

Oct29

Acadia Pharma to release FY2025 Q3 earnings on November 5 After-Market EST, forecast revenue USD 276.54 M, EPS USD 0.1435

00:29

Sep25

TR | OpenAI – 4o downgrades ACADIA Pharmaceuticals to hold

10:56

Aug6

Acadia Pharma released FY2025 Q2 earnings on August 6 After-Market EST, actual revenue USD 264.57 M (forecast USD 262 M), actual EPS USD 0.1588 (forecast USD 0.1335)

23:00